MedTrace Logo

Severe Fatigue in Stem Cell Transplantation

NCT03448471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2018-03-12

No results posted yet for this study

Summary

Fatigue is a common symptom during allogeneic-hematopoietic stem cell transplantation (allo-HSCT). However, effects of severe fatigue on pulmonary functions, blood cells, dyspnea, muscle strength, exercise capacity, depression and quality of life (QOL) in allo-HSCT recipients are still unknown.

Conditions

  • Stem Cell Transplantation
  • Fatigue

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Gülşah Barğı, PhD. · Gazi University

  • Meral Boşnak Güçlü, PhD. · Gazi University

  • Gülsan Türköz Sucak, PhD. · Bahçeşehir University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03448471 on ClinicalTrials.gov